FDA — authorised 29 December 1986
- Application: NDA019353
- Marketing authorisation holder: RISING
- Local brand name: ALFENTA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Alfenta in United States
FDA authorised Alfenta on 29 December 1986
Marketing authorisations
FDA — authorised 28 October 1999
- Application: ANDA075221
- Marketing authorisation holder: HOSPIRA
- Local brand name: ALFENTANIL
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
Alfenta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Alfenta approved in United States?
Yes. FDA authorised it on 29 December 1986; FDA authorised it on 28 October 1999; FDA has authorised it.
Who is the marketing authorisation holder for Alfenta in United States?
RISING holds the US marketing authorisation.